Immunohistochemical assessment of mitotic count in uveal melanoma

Acta Ophthalmologica

Volumn 89, Issue 2, 2011, Pages

  Angi, Martina ^a   Damato, Bertil ^a   Kalirai, Helen ^b   Dodson, Andrew ^b   Taktak, Azzam ^c   Coupland, Sarah E ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c Department of Medical Physics and Clinical Engineering ^*  (United Kingdom)

Author keywords

Disomy 3; Mitotic rate; Monosomy 3; Prognostication; Uveal melanoma

Indexed keywords

DYE; EOSIN; FORMALDEHYDE; HEMATOXYLIN; PARAFFIN; PHOSPHO HISTONE H3 SER10; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHOROID MELANOMA; COHORT ANALYSIS; ENUCLEATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; SCLERECTOMY; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; EYE ENUCLEATION; FEMALE; HISTONES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MELANOMA; MIDDLE AGED; MITOSIS; MITOTIC INDEX; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 79952239499     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01769.x     Document Type: Article

References (28)

1. Al-Jamal RT, Toivonen P & Kivela T (2009): Nucleolar size in choroidal and ciliary body melanomas and corresponding hepatic metastases. Acta Ophthalmol (Epub ahead of print).
2. Bossard C, Jarry A, Colombeix C, Bach-Ngohou K, Moreau A, Loussouarn D, Mosnier JF & Laboisse CL (2006): Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index. J Clin Pathol 59: 706-710. (Pubitemid 44048778)
3. Chowers I, Amer R & Pe'er J (2002a): The correlation among different immunostaining evaluation methods for the assessment of proliferative activity in uveal melanoma. Curr Eye Res 25: 369-372.
4. Chowers I, Folberg R, Livni N & Pe'er J (2002b): p53 Immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroid. Curr Eye Res 24: 105-108.
5. Colman H, Giannini C, Huang L et al. (2006): Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol 30: 657-664. (Pubitemid 44265019)
6. Coupland SE, Hiscott P, Smith P & Damato B (2006): Revisiting the value of assessing the mitotic rate of choroidal melanomas. Melanoma Res 16: S49.
7. Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, Douglas A & Howard P (2007): Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 114: 1925-1931.
8. Damato B, Eleuteri A, Fisher AC, Coupland SE & Taktak AF (2008): Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Ophthalmology 115: 1598-1607.
9. van Diest PJ, Baak JP, Matze-Cok P et al. (1992): Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23: 603-607.
10. Donhuijsen K (1986): Mitosis counts: reproducibility and significance in grading of malignancy. Hum Pathol 17: 1122-1125.
11. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J & Gruman LM (1993): The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100: 1389-1398.
12. Ghazvini S, Kroll S, Char DH & Frigillana H (1995): Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma. Invest Ophthalmol Vis Sci 36: 2762-2767.
13. Gurley LR, D'Anna JA, Barham SS, Deaven LL & Tobey RA (1978): Histone phosphorylation and chromatin structure during mitosis in Chinese hamster cells. Eur J Biochem 84: 1-15. (Pubitemid 8286682)
14. Hendzel MJ, Wei Y, Mancini MA, Van Hooser A, Ranalli T, Brinkley BR, Bazett-Jones DP & Allis CD (1997): Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106: 348-360. (Pubitemid 27510848)
15. Hendzel MJ, Nishioka WK, Raymond Y, Allis CD, Bazett-Jones DP & Th'ng JP (1998): Chromatin condensation is not associated with apoptosis. J Biol Chem 273: 24470-24478.
16. Juan G, Traganos F, James WM, Ray JM, Roberge M, Sauve DM, Anderson H & Darzynkiewicz Z (1998): Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 32: 71-77. (Pubitemid 28246753)
17. Kim YJ, Ketter R, Steudel WI & Feiden W (2007): Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas. Am J Clin Pathol 128: 118-125. (Pubitemid 47121724)
18. Kujala E, Makitie T & Kivela T (2003): Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 44: 4651-4659. (Pubitemid 37315273)
19. Kuopio T & Collan Y (1996): Mitotic count in breast cancer. The influence of training on performance. Pathol Res Pract 192: 1095-1099.
20. Lattman J, Kroll S, Char DH, Ghazvini S, Frigillana H, O'Brien JM & Elbakri HR (1995): Cell cycling and prognosis in uveal melanoma. Clin Cancer Res 1: 41-47.
21. Massey FJ (1951): The Kolmogorov-Smirnov Test for Goodness of Fit. J Am Stat Assoc 46: 68-78.
22. McLean MJ, Foster WD & Zimmerman LE (1977): Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol 95: 48-58. (Pubitemid 8258614)
23. Mooy CM, Luyten GP, de Jong PT, Luider TM, Stijnen T, van de Ham F, van Vroonhoven CC & Bosman FT (1995): Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. Am J Pathol 147: 1097-1104.
24. Pe'er J, Gnessin H, Shargal Y & Livni N (1994): PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups. Ophthalmology 101: 56-62.
25. Ribalta T, McCutcheon IE, Aldape KD, Bruner JM & Fuller GN (2004): The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol 28: 1532-1536. (Pubitemid 39425522)
26. Scolyer RA, Shaw HM, Thompson JF et al. (2003): Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol 27: 1571-1576. (Pubitemid 37486620)
27. Shapiro BE, Felberg NT, Donoso LA, Augsburger JJ, Shields JA & Gamel J (1986): Flow cytometry of uveal melanomas. Cancer Biochem Biophys 8: 235-238.
28. Tapia C, Kutzner H, Mentzel T, Savic S, Baumhoer D & Glatz K (2006): Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol 30: 83-89. (Pubitemid 43740213)